JAGSNPHARM

JAGSNPHARM · Corporate filings
NSE
Price & chart
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay

Stock market charts for JAGSNPHARM quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.

Loading financial charts...

Financial Results figures in ₹ crore, except EPS/%

Loading…

Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500

Loading…

CAN SLIM William O'Neil's growth-stock criteria

Loading…

Latest Shareholding Pattern promoter, FII, DII, public and institution trend NSE synced data

Loading shareholding pattern...

Corporate Governance SEBI integrated governance filing NSE synced data

Loading governance disclosure...

Announcements
Pharmaceuticals 08 Jul 2026
Updates
Pharmaceuticals 07 Jul 2026
Updates
Pharmaceuticals 06 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Pharmaceuticals 30 Jun 2026
Disclosure under SEBI Takeover Regulations
Pharmaceuticals 29 Jun 2026
Press Release
Pharmaceuticals 29 Jun 2026
General Updates
Pharmaceuticals 26 Jun 2026
Trading Window
Pharmaceuticals 25 Jun 2026
Press Release
Pharmaceuticals 25 Jun 2026
Change in Management
Pharmaceuticals 25 Jun 2026
Change in Director(s)
Pharmaceuticals 25 Jun 2026
Appointment
Pharmaceuticals 04 Jun 2026
Updates
Pharmaceuticals 03 Jun 2026
Disclosure under SEBI Takeover Regulations
Pharmaceuticals 02 Jun 2026
Closure of Buy Back
Pharmaceuticals 25 May 2026
Copy of Newspaper Publication
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Buy Back Buy Back Ex-date: 04 May 2026
Dividend - Rs 2.50 Per Share Dividend - Rs 2.50 Per Share Ex-date: 12 Sep 2025
Face Value Split (Sub-Division) - From Rs 5/- Per Share To Rs 2/- Per Share Face Value Split (Sub-Division) - From Rs 5/- Per Share To Rs 2/- Per Share Ex-date: 08 Jan 2025
Dividend - Rs 5 Per Share Dividend - Rs 5 Per Share Ex-date: 06 Sep 2024
Dividend - Rs 5 Per Share Dividend - Rs 5 Per Share Ex-date: 21 Aug 2023
Extra Ordinary General Meeting Extra Ordinary General Meeting Ex-date: 08 Jun 2022
Interim Dividend - Rs 4 Per Share Interim Dividend - Rs 4 Per Share Ex-date: 29 Oct 2021
Annual General Meeting/Dividend - Re 1 Per Share Annual General Meeting/Dividend - Re 1 Per Share Ex-date: 22 Sep 2021
Annual General Meeting/Dividend - Rs 0.50 Per Share Annual General Meeting/Dividend - Rs 0.50 Per Share Ex-date: 22 Sep 2020
Annual General Meeting/Dividend - Rs 0.25 Per Share Annual General Meeting/Dividend - Rs 0.25 Per Share Ex-date: 20 Sep 2019
Annual General Meeting/Dividend Re 0.10 Per Share Annual General Meeting/Dividend Re 0.10 Per Share Ex-date: 18 Sep 2018
Annual General Meeting/Dividend - Re 0.10 Per Share (Date Revised) Annual General Meeting/Dividend - Re 0.10 Per Share (Date Revised) Ex-date: 21 Sep 2017
Annual General Meeting/ Dividend - Re 0.10/- Per Share (Book Closure Start Date Revised) Annual General Meeting/ Dividend - Re 0.10/- Per Share (Book Closure Start Date Revised) Ex-date: 21 Sep 2016
Annual General Meeting/ Dividend - Re 0.10/- Per Share Annual General Meeting/ Dividend - Re 0.10/- Per Share Ex-date: 21 Sep 2015
Annual General Meeting / Dividend - Re 0.50/- Per Share Annual General Meeting / Dividend - Re 0.50/- Per Share Ex-date: 25 Sep 2014
Annual General Meeting/Dividend Re 0.50/- Per Share Annual General Meeting/Dividend Re 0.50/- Per Share Ex-date: 25 Sep 2013
Annual General Meeting/Dividend Re 0.50 Per Share Annual General Meeting/Dividend Re 0.50 Per Share Ex-date: 21 Sep 2012
Annual General Meeting And Dividend Re.0.50 Per Share Annual General Meeting And Dividend Re.0.50 Per Share Ex-date: 23 Sep 2011
Annual General Meeting And Dividend Re.0.50 Per Share Annual General Meeting And Dividend Re.0.50 Per Share Ex-date: 21 Sep 2010
Agm/Div-Re.0.25 Per Share Agm/Div-Re.0.25 Per Share Ex-date: 23 Sep 2009
Board Meetings
27 Apr 2026
JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 27-Apr-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
27 Apr 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
12 Mar 2026
JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 12-Mar-2026 to consider Buyback.
12 Mar 2026
To consider buyback for equity shares
12 Mar 2026
JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 12-Mar-2026 to consider Buyback.
21 Jan 2026
JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 21-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
21 Jan 2026
To consider and approve the financial results for the period ended December 31, 2025
03 Nov 2025
JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2025 .